Healthcare, Pharmaceuticals and Biotech

See All Insights See All Insights

See All Events See All Events

Kroll Life Sciences Webcast Series

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships. Kroll recently brought together our leading experts and industry leaders to share insights and trends on valuation, technology, intellectual property (IP), risk and regulation in a life sciences webcast series.

Watch Webcast Replays Watch Webcast Replays

Connect with us

Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.

Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.

Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.

Kroll recently spoke with intellectual property expert Alexandra Pygall, a partner at Stephenson Harwood LLP, on patent waivers for the COVID-19 vaccines. Watch this short video to learn more about how patent waivers play a role in the global distribution of vaccines and what it can mean for the future of the healthcare and pharmaceutical industries.

Stay Ahead with Kroll

Valuation Advisory

Valuation Advisory Services

Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.

Valuation Advisory Services
Healthcare M&A Advisory

Healthcare M&A

Healthcare expertise for middle-market M&A transactions.

Healthcare M&A
Cyber Risk

Cyber Risk

Incident response, digital forensics, breach notification, managed detection services, penetration testing, cyber assessments and advisory.

Cyber Risk
Security Risk Management

Security Risk Management

Helping clients anticipate and respond to a myriad of facility, operational and employee security challenges.

Security Risk Management
Financial Services Compliance and Regulation

Financial Services Compliance and Regulation

End-to-end governance, advisory and monitorship solutions to detect, mitigate, drive efficiencies and remediate operational, legal, compliance and regulatory risk.

Financial Services Compliance and Regulation
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services
Tax Services

Tax Services

Built upon the foundation of its renowned valuation business, Kroll's Tax Service practice follows a detailed and responsive approach to capturing value for clients.

Tax Services
Expert Services

Expert Services

Independent expert analysis, testimony, advice and investigations for complex disputes and projects.

Expert Services

Case Studies

Events

Opportunities and Challenges for Chinese Companies Listed in the US and Their Investors under Current Environment

Calendar

Location

Insights

Episode 3

Protection of Vaccine Supply Chain

Episode 3

News